124 related articles for article (PubMed ID: 4463002)
1. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
[No Abstract] [Full Text] [Related]
2. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
[No Abstract] [Full Text] [Related]
3. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
Sorensen TB; Kjaer M
Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
[TBL] [Abstract][Full Text] [Related]
4. Effect of leucocyte washings on cellular immunity to human renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1976 Oct; 12(10):783-92. PubMed ID: 1086209
[No Abstract] [Full Text] [Related]
5. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
Kjaer M; Bendixen G
Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the direct capillary tube leucocyte migration technique (LMCT) and the direct agarose leucocyte migration technique (LMAT) as indicators of tumour-directed cell-mediated hypersensitivity (TCMH) in patients with renal carcinoma.
Kjaer M; Sorensen IB
Acta Allergol; 1976 Apr; 31(2):141-58. PubMed ID: 947138
[TBL] [Abstract][Full Text] [Related]
7. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
Kjoer M
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
[No Abstract] [Full Text] [Related]
8. The dose-related effect of tumour extract on the in vitro migration of leucocytes from patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1975 Apr; 11(4):281-9. PubMed ID: 1095377
[No Abstract] [Full Text] [Related]
9. [Aspects of the study of immunity in patients with kidney tumors].
Trapeznikova MF; Kadagidze ZG; Abramian NS; Dutov VV
Urol Nefrol (Mosk); 1984; (4):18-21. PubMed ID: 6474622
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
[TBL] [Abstract][Full Text] [Related]
11. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
Novikov DK; Borisenko ID; Shein IA
Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
[TBL] [Abstract][Full Text] [Related]
12. General immunocompetence and tumour-directed, cell-mediated hypersensitivity in vitro in patients with renal carcinoma.
Kjaer M; Thomsen M
Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):403-13. PubMed ID: 136864
[TBL] [Abstract][Full Text] [Related]
13. In vitro demonstration of cellular hypersensitivity to strep 2A in recurrent aphthous stomatitis by means of the leucocyte migration test.
Donatsky O; Bendixen G
Acta Allergol; 1972 Apr; 27(2):137-44. PubMed ID: 5068538
[No Abstract] [Full Text] [Related]
14. Isolation of a soluble tumor-associated antigen from human renal cell carcinoma by gradient acrylamide gel electrophoresis.
Wright GL; Schellhammer PF; Faulconer RL
Cancer Res; 1977 Nov; 37(11):4228-32. PubMed ID: 911404
[No Abstract] [Full Text] [Related]
15. Tumour-induced, cell-mediated hypersensitivity in man. A critical review with special reference to leucocyte migration assays.
Kjaer M
Acta Allergol; 1976 Oct; 31(5):373-415. PubMed ID: 790887
[No Abstract] [Full Text] [Related]
16. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
Cummings KB; Peter JB; Kaufman JJ
J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
[No Abstract] [Full Text] [Related]
17. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
Pappas A; Schwarze G
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
[No Abstract] [Full Text] [Related]
18. Autoantibodies to human renal cell carcinoma.
Ravitz G; Watne AL; Milam DF
J Urol; 1972 Jan; 107(1):26-8. PubMed ID: 4550720
[No Abstract] [Full Text] [Related]
19. Cell-mediated immunity in prostatic cancer.
Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
[No Abstract] [Full Text] [Related]
20. Cellular immunity to renal carcinomas in man.
Bubeník J; Jakoubková J; Krákora P; Baresová M; Helbich P; Viklický V; Malasková V
Int J Cancer; 1971 Nov; 8(3):503-13. PubMed ID: 5137312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
